| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Molecular Dynamics Simulation | 13 | 2024 | 116 | 1.830 |
Why?
|
| Molecular Docking Simulation | 13 | 2023 | 127 | 1.100 |
Why?
|
| Computational Biology | 10 | 2024 | 887 | 0.900 |
Why?
|
| Mutation | 20 | 2024 | 6297 | 0.850 |
Why?
|
| Filamins | 1 | 2020 | 27 | 0.700 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2023 | 351 | 0.690 |
Why?
|
| Mutation, Missense | 5 | 2021 | 930 | 0.670 |
Why?
|
| Protein Domains | 1 | 2020 | 252 | 0.640 |
Why?
|
| Calcium-Binding Proteins | 1 | 2020 | 336 | 0.630 |
Why?
|
| Gene Regulatory Networks | 4 | 2023 | 397 | 0.620 |
Why?
|
| Signal Transduction | 6 | 2023 | 4899 | 0.600 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 289 | 0.600 |
Why?
|
| Cell-Free Nucleic Acids | 2 | 2023 | 58 | 0.580 |
Why?
|
| Models, Molecular | 1 | 2020 | 1132 | 0.540 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2024 | 190 | 0.530 |
Why?
|
| Systems Biology | 2 | 2021 | 63 | 0.530 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 1407 | 0.510 |
Why?
|
| Galactosemias | 2 | 2021 | 15 | 0.510 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 876 | 0.470 |
Why?
|
| Obesity | 2 | 2021 | 2416 | 0.460 |
Why?
|
| Breast Neoplasms | 5 | 2023 | 2763 | 0.440 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2022 | 406 | 0.430 |
Why?
|
| Thrombasthenia | 1 | 2023 | 2 | 0.420 |
Why?
|
| Integrin alpha2 | 1 | 2023 | 10 | 0.420 |
Why?
|
| Integrin beta3 | 1 | 2023 | 29 | 0.420 |
Why?
|
| Food Coloring Agents | 1 | 2023 | 3 | 0.410 |
Why?
|
| Prion Diseases | 1 | 2022 | 4 | 0.410 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2022 | 9 | 0.410 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2023 | 64 | 0.410 |
Why?
|
| Prions | 1 | 2022 | 16 | 0.400 |
Why?
|
| Wolman Disease | 1 | 2022 | 7 | 0.400 |
Why?
|
| Databases, Genetic | 3 | 2021 | 501 | 0.400 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2023 | 90 | 0.400 |
Why?
|
| Neoplasms | 3 | 2022 | 3027 | 0.400 |
Why?
|
| Tramadol | 1 | 2022 | 8 | 0.400 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 866 | 0.380 |
Why?
|
| Humans | 43 | 2024 | 133943 | 0.380 |
Why?
|
| Cell Cycle Proteins | 2 | 2023 | 697 | 0.370 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2021 | 19 | 0.370 |
Why?
|
| Skin Diseases | 1 | 2023 | 135 | 0.360 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2021 | 37 | 0.360 |
Why?
|
| GTP Phosphohydrolases | 1 | 2021 | 159 | 0.340 |
Why?
|
| Galactosylceramidase | 1 | 2020 | 2 | 0.340 |
Why?
|
| ras Proteins | 1 | 2021 | 146 | 0.340 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 2020 | 4 | 0.340 |
Why?
|
| Anti-Infective Agents | 1 | 2023 | 269 | 0.340 |
Why?
|
| Coronary Disease | 1 | 2024 | 722 | 0.340 |
Why?
|
| Water | 1 | 2021 | 198 | 0.330 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2022 | 178 | 0.330 |
Why?
|
| Phosphotransferases (Phosphomutases) | 1 | 2020 | 6 | 0.330 |
Why?
|
| UTP-Hexose-1-Phosphate Uridylyltransferase | 1 | 2019 | 6 | 0.330 |
Why?
|
| Multiple Myeloma | 1 | 2022 | 201 | 0.330 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2020 | 23 | 0.330 |
Why?
|
| Synovitis | 1 | 2020 | 26 | 0.330 |
Why?
|
| Pulmonary Emphysema | 1 | 2021 | 95 | 0.330 |
Why?
|
| Uveitis | 1 | 2020 | 38 | 0.320 |
Why?
|
| Sarcoidosis | 1 | 2020 | 62 | 0.320 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2020 | 44 | 0.320 |
Why?
|
| Arthritis | 1 | 2020 | 86 | 0.310 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2023 | 375 | 0.310 |
Why?
|
| Gene Expression Profiling | 6 | 2024 | 1910 | 0.300 |
Why?
|
| Protein Conformation | 4 | 2023 | 870 | 0.300 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 294 | 0.290 |
Why?
|
| Vaccines | 1 | 2023 | 380 | 0.290 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 607 | 0.290 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 377 | 0.290 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2022 | 2940 | 0.290 |
Why?
|
| Esophageal Neoplasms | 1 | 2022 | 393 | 0.280 |
Why?
|
| Receptor, ErbB-2 | 1 | 2020 | 559 | 0.270 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 648 | 0.260 |
Why?
|
| Kidney Transplantation | 1 | 2021 | 689 | 0.240 |
Why?
|
| Adenosine Triphosphate | 2 | 2023 | 295 | 0.240 |
Why?
|
| Leukodystrophy, Metachromatic | 1 | 2024 | 5 | 0.230 |
Why?
|
| Cerebroside-Sulfatase | 1 | 2024 | 9 | 0.230 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 2519 | 0.220 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2023 | 792 | 0.220 |
Why?
|
| Aspartylglucosaminuria | 1 | 2023 | 1 | 0.210 |
Why?
|
| Sequence Analysis | 1 | 2023 | 54 | 0.210 |
Why?
|
| Structure-Activity Relationship | 2 | 2023 | 611 | 0.200 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2023 | 50 | 0.200 |
Why?
|
| Thiolester Hydrolases | 1 | 2022 | 10 | 0.200 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2022 | 13 | 0.200 |
Why?
|
| Kirsten murine sarcoma virus | 2 | 2022 | 2 | 0.190 |
Why?
|
| Transcriptome | 3 | 2022 | 1127 | 0.190 |
Why?
|
| BRCA1 Protein | 1 | 2022 | 82 | 0.190 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 1788 | 0.180 |
Why?
|
| Extensively Drug-Resistant Tuberculosis | 1 | 2021 | 9 | 0.180 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2022 | 115 | 0.180 |
Why?
|
| UDPglucose 4-Epimerase | 1 | 2021 | 7 | 0.180 |
Why?
|
| Ebolavirus | 1 | 2021 | 47 | 0.180 |
Why?
|
| Chemical Phenomena | 1 | 2020 | 88 | 0.180 |
Why?
|
| Guanosine Diphosphate | 1 | 2020 | 13 | 0.180 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2020 | 12 | 0.180 |
Why?
|
| Angiotensinogen | 1 | 2020 | 25 | 0.180 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2021 | 59 | 0.170 |
Why?
|
| Guanosine Triphosphate | 1 | 2020 | 52 | 0.170 |
Why?
|
| Plant Proteins | 1 | 2021 | 91 | 0.170 |
Why?
|
| Solvents | 1 | 2020 | 46 | 0.170 |
Why?
|
| Renin | 1 | 2020 | 88 | 0.170 |
Why?
|
| Databases, Nucleic Acid | 1 | 2020 | 74 | 0.170 |
Why?
|
| Lipolysis | 1 | 2020 | 80 | 0.170 |
Why?
|
| Facies | 1 | 2020 | 154 | 0.170 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2020 | 95 | 0.170 |
Why?
|
| Osteochondrodysplasias | 1 | 2020 | 68 | 0.170 |
Why?
|
| Sjogren-Larsson Syndrome | 1 | 2020 | 2 | 0.170 |
Why?
|
| Receptors, LDL | 1 | 2020 | 102 | 0.170 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2020 | 20 | 0.170 |
Why?
|
| Fibrinogen | 1 | 2020 | 164 | 0.160 |
Why?
|
| Dwarfism | 1 | 2020 | 102 | 0.160 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2021 | 173 | 0.160 |
Why?
|
| Adipocytes | 1 | 2020 | 166 | 0.160 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2020 | 129 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2023 | 508 | 0.160 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 392 | 0.150 |
Why?
|
| Exome | 1 | 2023 | 1067 | 0.150 |
Why?
|
| Protein Interaction Maps | 2 | 2022 | 89 | 0.140 |
Why?
|
| Biomarkers, Tumor | 3 | 2023 | 1720 | 0.140 |
Why?
|
| Evolution, Molecular | 1 | 2020 | 709 | 0.130 |
Why?
|
| Protein Stability | 2 | 2021 | 172 | 0.130 |
Why?
|
| Membrane Proteins | 2 | 2022 | 1606 | 0.130 |
Why?
|
| Apoptosis | 2 | 2023 | 1930 | 0.120 |
Why?
|
| Bacterial Proteins | 1 | 2021 | 930 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2020 | 870 | 0.120 |
Why?
|
| Tablets | 1 | 2024 | 36 | 0.110 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2024 | 24 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2020 | 1621 | 0.100 |
Why?
|
| Erythromycin | 1 | 2023 | 21 | 0.100 |
Why?
|
| Prion Proteins | 1 | 2022 | 4 | 0.100 |
Why?
|
| Pancreatic Elastase | 1 | 2023 | 14 | 0.100 |
Why?
|
| Collagenases | 1 | 2023 | 18 | 0.100 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2023 | 25 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2023 | 90 | 0.100 |
Why?
|
| Smad4 Protein | 1 | 2023 | 58 | 0.100 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2023 | 30 | 0.100 |
Why?
|
| Sterol Esterase | 1 | 2022 | 20 | 0.100 |
Why?
|
| Azithromycin | 1 | 2023 | 47 | 0.100 |
Why?
|
| Iran | 1 | 2022 | 92 | 0.100 |
Why?
|
| Protein Structure, Secondary | 1 | 2023 | 253 | 0.100 |
Why?
|
| Immunoglobulin M | 1 | 2023 | 224 | 0.100 |
Why?
|
| Paroxetine | 1 | 2022 | 29 | 0.100 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2022 | 18 | 0.100 |
Why?
|
| Lipase | 1 | 2022 | 98 | 0.100 |
Why?
|
| Rifampin | 1 | 2023 | 134 | 0.100 |
Why?
|
| Aurora Kinase A | 1 | 2022 | 38 | 0.100 |
Why?
|
| Ultraviolet Rays | 1 | 2023 | 215 | 0.100 |
Why?
|
| AAA Domain | 1 | 2021 | 1 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 2656 | 0.090 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2023 | 204 | 0.090 |
Why?
|
| Tacrolimus | 1 | 2021 | 107 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2022 | 182 | 0.090 |
Why?
|
| Fasting | 1 | 2022 | 311 | 0.090 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2020 | 111 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2023 | 626 | 0.080 |
Why?
|
| Algorithms | 2 | 2022 | 1736 | 0.080 |
Why?
|
| Galactosephosphates | 1 | 2019 | 4 | 0.080 |
Why?
|
| UDPglucose-Hexose-1-Phosphate Uridylyltransferase | 1 | 2019 | 3 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 486 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2022 | 2122 | 0.080 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 828 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2022 | 381 | 0.080 |
Why?
|
| Binding Sites | 2 | 2024 | 1370 | 0.080 |
Why?
|
| Lipids | 1 | 2022 | 568 | 0.080 |
Why?
|
| Phylogeny | 2 | 2021 | 784 | 0.080 |
Why?
|
| Female | 7 | 2023 | 71684 | 0.070 |
Why?
|
| Fibroblasts | 1 | 2023 | 922 | 0.070 |
Why?
|
| Gene Expression | 1 | 2023 | 1614 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2022 | 1193 | 0.070 |
Why?
|
| Glucose | 1 | 2022 | 924 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 693 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2022 | 1242 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2022 | 869 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2022 | 2781 | 0.070 |
Why?
|
| Genotype | 1 | 2021 | 2807 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 3751 | 0.060 |
Why?
|
| Aged | 1 | 2023 | 21746 | 0.060 |
Why?
|
| Motor Neuron Disease | 1 | 2024 | 20 | 0.060 |
Why?
|
| Metals | 1 | 2024 | 64 | 0.050 |
Why?
|
| Aspartylglucosylaminase | 1 | 2023 | 1 | 0.050 |
Why?
|
| Hydrogen Bonding | 1 | 2023 | 87 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2023 | 4822 | 0.050 |
Why?
|
| Drug Repositioning | 1 | 2023 | 31 | 0.050 |
Why?
|
| Phenotype | 1 | 2023 | 4548 | 0.050 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 82 | 0.050 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2022 | 62 | 0.050 |
Why?
|
| Biomarkers | 2 | 2022 | 3426 | 0.050 |
Why?
|
| Metabolic Engineering | 1 | 2021 | 6 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2022 | 238 | 0.050 |
Why?
|
| Quality of Life | 1 | 2021 | 2143 | 0.050 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2021 | 68 | 0.040 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2021 | 15 | 0.040 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2021 | 16 | 0.040 |
Why?
|
| Immune System | 1 | 2022 | 98 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2022 | 6664 | 0.040 |
Why?
|
| Biocatalysis | 1 | 2021 | 36 | 0.040 |
Why?
|
| NAD | 1 | 2021 | 47 | 0.040 |
Why?
|
| Databases, Protein | 1 | 2021 | 63 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2021 | 283 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2021 | 311 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2022 | 8591 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 388 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2023 | 1701 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2022 | 510 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 554 | 0.030 |
Why?
|
| Animals | 2 | 2023 | 36388 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1832 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2023 | 2539 | 0.030 |
Why?
|
| Mice | 1 | 2023 | 18909 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 1599 | 0.030 |
Why?
|
| Genomics | 1 | 2021 | 1676 | 0.030 |
Why?
|
| Child | 1 | 2022 | 25742 | 0.020 |
Why?
|
| Male | 2 | 2022 | 65904 | 0.020 |
Why?
|